STXS News and Press, Stereotaxis Inc.

2026-03-13 08:15:00 ET Stereotaxis Overview Read the full article on Seeking Alpha For further details see: Stereotaxis: Medical Robotics Upside Offsets Cash Burn And Execution Risks

2026-03-09 20:18:34 ET More on Stereotaxis Stereotaxis, Inc. (STXS) Q4 2025 Earnings Call Transcript Seeking Alpha’s Quant Rating on Stereotaxis Historical earnings data for Stereotaxis Financial information for Stereotaxis Read the full arti...

2026-03-09 20:17:57 ET Stereotaxis, Inc. (STXS) Q4 2025 Earnings Call March 9, 2026 4:30 PM EDT Company Participants David Fischel - CEO & Chairman Kimberly Peery - Chief Financial Officer Conference Call Participants Daniel Stauder - Citizens JMP S...

2026-03-09 16:05:02 ET More on Stereotaxis Seeking Alpha’s Quant Rating on Stereotaxis Historical earnings data for Stereotaxis Financial information for Stereotaxis Read the full article on Seeking Alpha For further details see: Stereotaxi...

ST. LOUIS, March 09, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the fourth quarter and full year ended December 31, 2025. “The past year saw t...

2026-03-08 08:07:45 ET Despite a relatively light earnings calendar, the upcoming earnings week will offer investors a broad look across multiple sectors, from technology and EVs to retail, mining, and biotech, as several notable companies report results. ... Read the full articl...

2026-03-06 17:35:01 ET More on Stereotaxis Seeking Alpha’s Quant Rating on Stereotaxis Historical earnings data for Stereotaxis Financial information for Stereotaxis Read the full article on Seeking Alpha For further details see: Stereotaxi...

ST. LOUIS, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2025 fourth quarter and full year on Monday, March 9, 2026 at ...

ST. LOUIS, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the launch of a new robotic electrophysiology program at Klinikum Fürth in Fürth, Germany. Klinikum...

ST. LOUIS, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it obtained U.S. Food and Drug Administration (FDA) approval for the MAGiC™ Magnetic Interventional Abla...